Viewing nowCombinationTelmisartan and Amlodipine Tablets 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daewon BioTech Co., Ltd.

MFDS item code 201908433 · Approved 2019.12.16 · Insurance code 057600440
Treatment of essential hypertension not controlled with monotherapy
This medication effectively lowers blood pressure in patients with essential hypertension who do not achieve adequate blood pressure control with amlodipine or telmisartan monotherapy. For those who find it difficult to manage their blood pressure, taking this medicine reduces the strain on the heart and blood vessels, thereby improving overall health. This drug is used to stabilize blood pressure management and to reduce the risk of cardiovascular complications.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, switching directly to this medicine may be considered when blood pressure is not controlled with an individual component, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if administered during pregnancy, especially in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with hypersensitivity to the active ingredients, severe liver impairment, hypotension, heart failure, or unstable condition following acute myocardial infarction. Caution is advised for patients with impaired liver function, certain cardiac valve diseases, decreased kidney function, the elderly, etc. During treatment, side effects such as dizziness, peripheral edema, palpitations, and hypotension may occur, and if these symptoms are severe, medical advice should be sought immediately. As this drug lowers blood pressure, appropriate measures must be taken if symptoms of hypotension arise during treatment, particularly for patients who are deficient in fluids or salt. There is a risk of elevated potassium levels in the blood; therefore, regular monitoring of serum potassium levels is necessary when used in conjunction with potassium supplements or potassium-containing medications. Patients with impaired kidney function should undergo frequent monitoring relevant to kidney function while taking this medication, and safety for kidney transplant patients has not been fully established. This medication may interact with other antihypertensives or specific medications, so patients should inform their healthcare providers of any other medications they are taking. Pregnant and breastfeeding women should not take this medication, and if confirmed during pregnancy, it should be discontinued immediately and alternative treatment should be sought. Safety and efficacy have not been sufficiently established for use in children under 18 years of age, so it is not recommended. Elderly patients may respond more sensitively to this medication, so they should take it with caution and adjust the dosage accordingly. In cases of overdose, severe symptoms such as hypotension, dizziness, and cardiac dysfunction may occur; therefore, adherence to the prescribed dosage is essential, and emergency treatment should be sought in case of overdose. Store this medication out of reach of children and keep it in its original packaging for safety. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container protected from light, preferably at room temperature between 1 to 30 degrees Celsius. Storing this way helps maintain the medication's efficacy and safety.
Biconvex, oval, double-layered tablet in white and light gray.
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daewon BioTech Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.